New Study Links Common Cholesterol-Lowering Drugs To Reduced Prostate Cancer Risk
Men who take even small amounts of common cholesterol-lowering drugs such as Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer, according to a new study by Oregon Health & Science University Cancer Institute researchers.